DOCSLIB.ORG

The Editors of the Journal Ofclinical Investigation Gratefully

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Editors of the Journal Ofclinical Investigation Gratefully The Editors ofThe Journal ofClinical Investigation gratefully acknowledge the assistance ofthefollowing reviewers who served during the periodfrom 1 August 1989 through 31 July 1990. Stuart Aaronson Gordon Amidon Lloyd Axelrod Daniel Beauchamp Nanette H. Paul Bormstein Francois M. Claude Amiel Ole Baadsgaard Arthur Beaudet Bishopric Gerry R. Boss Abboud Arthur J. Ammann Bernard M. Babior Daniel Bechard D. Montgomery G. F. Bottazzo Hanna E. Abboud Helmut V. Ammon Robert J. Bache Lewis C. Becker Bissell Elias H. Botvinick George Abela Athanasius Bruce R. Bacon Richard Behringer Mina J. Bissell Claude Bouchard Dana R. Anagnostou David Bader David A. Bell Peter Bitterman Richard C. Abendschein Clark L. Anderson Kamal F. Badr Graeme I. Bell Ingemar Bjorkhem Boucher J. A. Abildskov Donald C. Steinun Norman H. Bell Robert E. Black Andrew J. M. Janis Abkowitz Anderson Baekkeskov William R. Bell William G. Boulton Robert T. Abraham Jeffrey L. Anderson Jacques U. Joseph A. Bellanti Blackard Bonno N. Bouma Dale R. Robert J. Anderson Baenziger Sam Benchimol George L. Daniel Bowen- Abrahamson Sharon Anderson Grover C. Bagby Earl P. Benditt Blackburn Pope Donald I. Abrams Giuseppe Andres Marco Baggiolini William E. Benitz Perry Blackshear Laurence Boxer Christine Abrass Reubin Andres Corrado Baglioni Joel S. Bennett Paul Blake Linda Boxer Naji N. Abumrad Aubie Angel Andrew D. Baines John E. Bennett J. Edwin Blalock Aubrey E. Boyd Hugh Ackerman Harry N. Dorothy Bainton Michael Bennett Rebecca Blanton James L. Boyer Steven Ackerman Antoniades Andrew Baird Vann Bennett Roland C. Blantz Thomas Boyer Brian A. Ackrell Asok C. Antony Robert S. Balaban Neal L. Benowitz Terrence F. Mary B. Boyle Daniel Acosta M. Sawkat Anwer R. Balfour-Sartor Andre Bensadoun Blaschke William Bradley Dolph 0. Adams Thomas T. Aoki William Balistreri Merrill D. Benson Bonnie Blazer-Yost Roscoe 0. Brady John Stirling Richard G. Appel Philip L. Ballard Edward Benz Andres Thomas Ernest Brahn Adams Stanley H. Appel Nazzareno Barry B. Bercu Blei Robert A. Branch Eileen Adamson Fred Applebaum Ballatori Melvin Berger Laurence M. Stephen Brand Burt Adelman Debra Applebaum- Barbara J. Nathan A. Berger Blendis Mark Brantly N. Franklin Bowden Ballerman Richard N. Berman Alexander Bloch Daniel Branton Adkinson Michael Appleman James E. Balow Steven R. Craig Bloch Alan R. Brash Sheldon Adler Fausto Araujo Michael Banda Bergmann Kenneth D. Bloch Douglas E. Brash Stephen Adler Leonard A. Arbeit Albert J. Banes Daniel E. Bergsagel Barry S. Block Thomas A. Brasitus Bharat B. Aggarwal Gordon L. Archer Norman Bank Bradford C. Berk Edward Block Clifford A. Brass Peter Agre William P. Arend Luciano Barajas Paul D. Berk Sherman Bloom Eric P. Brass Greti Aguilera William J. Jose J. Barbosa Lee R. Berkowitz Joseph Bloomer Lawrence F. Brass Dennis J. Ahnen Arendshorst Alan Barbour Ross Berkowitz Colin Bloor George A. Bray Philip Aisen Allen I. Arieff C. Wayne Bardin Judy Berliner Jeffrey A. Paul F. Bray Masood Akhtar M. Amin Arnaout Bart Barlogie P. A. Berman Bluestone Peter C. Brazy Quais Al-Awqati Barry G. W. Stephen Barnes Michael Berndt Robert J. Boackle Eric Bremer Rafeul Alam Arnason Alain D. Baron Alan Bernstein Bruce S. Bochner Murray F. Brennan Steven Albelda Claude D. Arnaud Roland Baron Daniel Bernstein Susan C. Bock Patrick J. Brennan John J. Albers Phillipe Arnaud J. A. Barranger I. Leonard Sarah Bodary Barry M. Brenner Richard K. Albert Peter Amer Douglas J. Barrett Bernstein Guenther Boden David A. Brenner A. Michael Albisser Frank C. Arnett Eugene Barrett Robert Bernstein Henry Dean E. Brenner Edwin L. Andrew Arnold Kim E. Barrett Christine Berry Bodenheimer Robert S. Bresalier Alderman Frederick R. William Barry Donald M. Bers G. H. J. Boers Julie A. Breyer Edward A. Aronson Gregory S. Barsh Joseph R. Bertino Clifton Bogardus Matthew Breyer Alexander Carmen Arroya Carol Basbaum Palmer Q. Bessey C. Richard Boland John H.B. Bridge R. Wayne Ann Arvin David Bass Ernest Beutler Robert Bolli Josephine Briggs Alexander Adam Asch Nathan M. Bass Christopher Bever W. Kline Bolton Kenneth L. Allen C. Alfrey Nancy Ascher Robert Bast Michael Bevilacqua Constantin Bona Brigham Lynn Allen- Philip W. Askenase Joan M. Bathon Italo Biaggioni Benjamin David Briles Hoffman Richard Aster Daniel Batlle David Bickers Bonavida Constance E. Anthony C. Allison John P. Atkinson Mark Batshaw June L. Biedler Lynda Bonewald Brinckerhoff Chester A. Alper Steven Atlas Eugene A. Bauer John Bienenstock Jean-Philippe F. Richard Robert J. Alpern Kenneth A. Ault Robert Baughman Edward Biglieri Bonjour Bringhurst David H. Alpers Gerald D. Aurbach Michael G. Baum Daniel D. Bikle Herbert L. Michael R. Bristow Fred Alt Steven D. Aust Heinz Baumann Lyman Bilharz Bonkowsky Bradley E. Britigan Blanche Alter K. Frank Austen Linda L. David Bilheimer Susan Bonner-Weir Arthur E. Broadus Amnon Altman Dominic Bausserman Margaret Joseph V. Garrett Brodeur Leonard C. Altman Autelitano John D. Baxter Billingham Bonventre Jerome S. Brody Ruth A. Altschuld Mary Ellen Avery David Baylink Henry J. Binder John R. Border Frank P. Brooks John M. Amatruda Ellis D. Avner Christine Baylis Richard J. Bing Wayne A. Border Virginia Broudy Julian L. Ambrus Joseph Avruch John W. Baynes Morris Birnbaum J. S. Borer David Brown Bruce N. Ames Midori Awazu Mohammad Bazzi J. Michael Bishop Bengt Borgstrom Dennis Brown Eric Brown Carlos J. Carrera Mario Chojkier C. Richard Conti Riccardo Dalla- Robert B. Dickson James K. Brown John D. Carroll Inder J. Chopra Daniel L. Cook Favera Paul E. DiCorleto Michael A. Michael Carroll J. Roy Chowdhury James D. Cook Mary F. Dallman Anna Mae Diehl Brownlee George Carruthers Peter Christmas Helen Cooke Peter R. Dallman John M. Dietschy Michael Dennis A. Carson George Chrousos Allen D. Cooper Caroline H. Michael Brownstein D. Martin Carter Streamson Chua David Cooper Damsky DiGiovanna Carlo Brugnara William G. Carter Dominic Chung George Cooper Eliot Danforth Mark Dillingham John A. C. Thomas Caskey S. I. Chung J. Allen D. Cooper Chi Dang Wolfang Dillman Brumbaugh Gail H. Cassell Paul Churchill Max D. Cooper Thomas Daniel Robert Dimand Hans R. Brunner Francis J. Frank Chytil James Corasanti Ronald P. Daniele Salvatore DiMauro Gail A. Bruns Castellino Douglas B. Cines Laurence Corash Barbara S. Daniels Charles Dinarello John D. Brunzell John Castellot Mortimer M. Civan J. D. Corbin Keld Dano Clark Distelhorst Douglas Buckley Rod L. Casto Curt I. Civin Lawrence Corey David R. Dantzker William Dittman Rebecca H. C. William Castor Henry N. Claman Barbara Corkey James H. Dauber Vishva M. Dixit Buckley Edgar S. Cathcart B. J. Clark Gibbons G. William H. Julie Djeu Carl K. Buckner Kevin J. Catt Joan G. Clark Cornwell Daughaday Alexander Amer Budayr George Caughey Robert A. Clark Roberto Coronado Chella David Dobrovic Lawrence B. John P. Caulfield Steven Clark Peter B. Corr John R. David Dennis E. Doherty Bugaisky Michael J. Robert Clarke Maria Almira Jeffrey Davidson G. Lynis Dohm Fritz Buhler Caulfield Thomas B. Correia Earl W. Davie Paul Dolber Ronald N. Buick Ralph R. Cavalieri Clarkson Jean A. Cortner Kay E. Davies Raphael Dolin L. Maximilian Buja Druie E. Cavender Peter Clayton Jeremiah Costello Peter F. Davies D. J. Donaldson J. Chloe Bulinski John J. Cebra Loran Clement Paul J. Cote Jean Davignon Virginia H. F. Merlin Bumpus John P. Cello John Clements Thomas M. Cotner Paul Davis Donaldson H. Franklin Bunn Michael Centrella John A. Clements Ramzi S. Cotran Roger A. Davis Robert M. Paul A. Bunn Anthony Cerami Kenneth J. Eric Cottington W. Bruce Davis Donaldson, Jr. R. A. Bunning Frank B. Cerra Clemetson Shaun R. Coughlin Michael A. Davitz Arthur Donohue- Steven J. Burakoff Bruce A. Chabner David R. Kenneth Courtney Ghislain De Rolfe Raymond F. Burk Alan Chait Clemmons William G. Couser Vroede Mark Donowitz Thomas J. Burke Tova Chajek-Shaul Martin J. Cline Kenneth Cowan Dorr G. Dearborn Martin E. Dorf Daniel Burkhoff Thomas J. Paul Coates Allen W. Cowley Richard E. J. Dorhout Mees Thomas F. Burks Chambers Jack W. Coburn Charles Cox Decklebaum Kenneth John C. Burnett Edward Chan Charles Cochrane David R. Cox George S. Deepe Dorshkind Thomas W. Burns Laurence Chan Robert L. Coffman Kenneth Cox Leslie J. DeGroot Janice Douglas Samuel A. Burstein Lawrence Chan Alan S. Cohen Malcom C. L. Cox Albert B. Steven K. Dower Maria G. Buse Yun-Lai Chan Allen B. Cohen David W. Crabb Deisseroth Jeffrey M. Drazen David A. Britton Chance Amos Cohen Joe Craft E.A. Deitch Boris Draznin Bushinsky Donna K. F. Carl M. Cohen James Crapo John Del Valle Mark K. Drezner Elsworth R. Chandler David E. Cohen Patricia Craven Terry L. Delovitch David J. Drutz Buskirk Eugene Chang Fred E. Cohen James Crawford Hector F. DeLuca Thomas D. DuBose William W. Busse David D. Chaplin Harvey J. Cohen Mark A. Creager Peter J. Delves Ronald Dubrevil Eugene Butcher Harold Chapman Myron S. Cohen Abla Creasey Robert H. Demling William C. Joel Buxbaum Alan N. Charney Phillip L. Cohen A. Creutzig David W. Duckworth Denis Buxton Israel Charo Richard A. Cohen Bruce N. Cronstein Dempster Nicholas P. B. Peter H. Byers Herbert S. Chase Robert Cohen George A. M. Cross Vincent Dennis Dudman Richard Calderone Kanu Chatterjee Sidney Cohen David Crutchley Peter Densen Elizabeth Duell Robert Califf Gautam Chaudhuri D. H. Cohn Ponciano D. Cruz Frederick R. Maria L. Dufau Doris H. Calloway Irshad H. Chaudry Jay N. Cohn Phillip E. Cryer DeRubertis Henry J. Duff Donald L. Irvin S. Y. Chen F. Sessions Cole Ronald G. Crystal Rik Derynck Michael E. Duffey Campbell Pojen P. Chen Peter S. Coleman Gerald R. Cunha Christian F. Jacques E. Dumont Edward J. Y. D. Ida Chen R. Edward Charlotte Deschepper Paul H. Duray Campbell Pi-Wan Cheng Coleman Cunningham- Robert J. Desnick Scott Durum Ernesto Canalis Savio Cheng Desire Collen Rundles Thomas C.
Load more

Recommended publications
  • Prospects and Challenges for the Global Nuclear Future: After Fukushima Scott D
    Spring_2012_COVER 4/23/2012 10:32 AM Page 3 american academy of arts & sciences spring 2012 www.amacad.org Bulletin vol. lxv, no. 3 Prospects and Challenges for the Global Nuclear Future: After Fukushima Scott D. Sagan, Harald Müller, Noramly bin Muslim, Olli Heinonen, and Jayantha Dhanapala The Future of the American Military Karl W. Eikenberry, John L. Hennessy, James J. Sheehan, David M. Kennedy, and William J. Perry ALSO: Patrick C. Walsh, M.D., Awarded the Francis Amory Prize Humanities Indicators Track Signi½cant Changes in the Disciplines Strengthening Energy Policy through Social Science WikiLeaks and the First Amendment Upcoming Events Special Thanks to Donors APRIL ore than $5.2 million was raised in the ½scal year completed on March 31, 25th M 2012. The Academy’s Annual Fund sur- Project Brie½ng–Washington, D.C. passed the $1.6 million mark for the ½rst The Alternative Energy Future time. Additional gifts and grants totaled Speakers: Steven Koonin (Institute for over $3.6 million, with more than 1,200 in- Defense Analyses; formerly, U.S. Depart- dividuals, 14 foundations, and 54 University ment of Energy); Robert Fri (Resources Af½liates contributing to make these results for the Future); Michael Graetz (Colum- possible. “This was a very successful year,” bia Law School); Michael Greenstone said Alan Dachs, Development and Public (Massachusetts Institute of Technology; Relations Committee Chair. “The Academy Brookings Institution); Kassia Yanosek is fortunate that so many Fellows support (Stanford University; Tana Energy the work we are doing.” Dachs expressed his Capital llc) deep appreciation to the members of the De- velopment Committee during the past year, MAY including Louise Bryson, Richard Cavanagh, 14th Jesse Choper, David Frohnmayer, Michael Reception–New York City Gellert, Matthew Santirocco, Stephen Reception in Honor of New York Area Fellows Stamas, Donald Stewart, Samuel Thier, and Nicholas Zervas, along with the continuing 16th involvement of Board Chair Louis Cabot.
    [Show full text]
  • Dr. Florence P. Haseltine, Ph.D., M.D. Activities of the Foundation While Bringing Recognition to a Worthy Woman in Medicine
    The Foundation for the History of Women in Medicine The 14th Annual The Foundation for the History of Women in Medicine, established in 1998, was founded on the belief that knowing the historical past is a powerful force in shaping Alma Dea Morani, M.D. the future. Though relatively young, The Foundation for the History of Women in Medicine has made significant accomplishments in promoting the history of Renaissance Woman Award women in medicine. The Alma Dea Morani Award continues to provide an annual centerpiece to the Dr. Florence P. Haseltine, Ph.D., M.D. activities of The Foundation while bringing recognition to a worthy woman in medicine. This year we honor Florence P. Haseltine, Ph.D., M.D., Emerita Director, Center for Population Research at the Eunice Kennedy Shriver National Institute for Public Health (NICHD) of the National Institutes of Health. The Foundation’s Research Fellowships, offered in conjunction with the The Archives for Women in Medicine (AWM) at Countway Library’s Center for the History of Medicine at Harvard Medical School, continue to be competitive. The 2013 recipient, Dr. Ciara Breathnach, lectures in history and has published on Irish socio-economic and health histories in the nineteenth and twentieth centuries. Her research focuses on how the poor experienced, engaged with and negotiated medical services in Ireland and in North America from 1860-1912. Dr. Breathnach’s focused study of record of the migratory waves against trends in medical and social modernity processes, are held at the Archives for Women in Medicine at the Countway Library and will be weighed against other socio-economic evidence to establish how problematic groups such as the Irish poor affected and shaped medical care in Boston.
    [Show full text]
  • Focal Eosinophilic Myositis Presenting with Leg Pain and Tenderness
    CASE REPORT Ann Clin Neurophysiol 2020;22(2):125-128 https://doi.org/10.14253/acn.2020.22.2.125 ANNALS OF CLINICAL NEUROPHYSIOLOGY Focal eosinophilic myositis presenting with leg pain and tenderness Jin-Hong Shin1,2, Dae-Seong Kim1,2 1Department of Neurology, Research Institute for Convergence of Biomedical Research, Pusan National University Yangsan Hospital, Yangsan, Korea 2Department of Neurology, Pusan National University School of Medicine, Yangsan, Korea Focal eosinophilic myositis (FEM) is the most limited form of eosinophilic myositis that com- Received: September 11, 2020 monly affects the muscles of the lower leg without systemic manifestations. We report a Revised: September 29, 2020 patient with FEM who was studied by magnetic resonance imaging and muscle biopsy with Accepted: September 29, 2020 a review of the literature. Key words: Myositis; Eosinophils; Magnetic resonance imaging Correspondence to Dae-Seong Kim Eosinophilic myositis (EM) is defined as a group of idiopathic inflammatory myopathies Department of Neurology, Pusan National associated with peripheral and/or intramuscular eosinophilia.1 Focal eosinophilic myositis Univeristy School of Medicine, 20 Geu- mo-ro, Mulgeum-eup, Yangsan 50612, (FEM) is the most limited form of EM and is considered a benign disorder without systemic 2 Korea manifestations. Here, we report a patient with localized leg pain and tenderness who was Tel: +82-55-360-2450 diagnosed as FEM based on laboratory findings, magnetic resonance imaging (MRI), and Fax: +82-55-360-2152 muscle biopsy. E-mail: [email protected] ORCID CASE Jin-Hong Shin https://orcid.org/0000-0002-5174-286X A 26-year-old otherwise healthy man visited our outpatient clinic with leg pain for Dae-Seong Kim 3 months.
    [Show full text]
  • A Acanthosis Nigricans, 139 Acquired Ichthyosis, 53, 126, 127, 159 Acute
    Index A Anti-EJ, 213, 214, 216 Acanthosis nigricans, 139 Anti-Ferc, 217 Acquired ichthyosis, 53, 126, 127, 159 Antigliadin antibodies, 336 Acute interstitial pneumonia (AIP), 79, 81 Antihistamines, 324 Adenocarcinoma, 115, 116, 151, 173 Anti-histidyl-tRNA-synthetase antibody Adenosine triphosphate (ATP), 229 (Anti-Jo-1), 6, 14, 140, 166, 183, Adhesion molecules, 225–226 213–216 Adrenal gland carcinoma, 115 Anti-histone antibodies (AHA), 174, 217 Age, 30–32, 157–159 Anti-Jo-1 antibody syndrome, 34, 129 Alanine aminotransferase (ALT, ALAT), 16, Anti-Ki-67 antibody, 247 128, 205, 207, 255 Anti-KJ antibodies, 216–217 Alanyl-tRNA synthetase, 216 Anti-KS, 82 Aldolase, 14, 16, 128, 129, 205, 207, 255, 257 Anti-Ku antibodies, 163, 165, 217 Aledronate, 325 Anti-Mas, 217 Algorithm, 256, 259 Anti-Mi-2 Allergic contact dermatitis, 261 antibody syndrome, 11, 129, 215 Alopecia, 62, 199, 290 antibodies, 6, 15, 129, 142, 212 Aluminum hydroxide, 325, 326 Anti-Myo 22/25 antibodies, 217 Alzheimer’s disease-related proteins, 190 Anti-Myosin scintigraphy, 230 Aminoacyl-tRNA synthetases, 151, 166, 182, Antineoplastic agents, 172 212, 215 Antineoplastic medicines, 169 Aminoquinolone antimalarials, 309–310, 323 Antinuclear antibody (ANA), 1, 141, 152, 171, Amyloid, 188–190 172, 174, 213, 217 Amyopathic DM, 6, 9, 29–30, 32–33, 36, 104, Anti-OJ, 213–214, 216 116, 117, 147–153 Anti-p155, 214–215 Amyotrophic lateral sclerosis, 263 Antiphospholipid syndrome (APS), 127, Antisynthetase syndrome, 11, 33–34, 81 130, 219 Anaphylaxi, 316 Anti-PL-7 antibody, 82, 214 Anasarca,
    [Show full text]
  • Muscle Biopsy Features of Idiopathic Inflammatory Myopathies And
    Autoimmun Highlights (2014) 5:77–85 DOI 10.1007/s13317-014-0062-2 REVIEW ARTICLE Muscle biopsy features of idiopathic inflammatory myopathies and differential diagnosis Gaetano Vattemi • Massimiliano Mirabella • Valeria Guglielmi • Matteo Lucchini • Giuliano Tomelleri • Anna Ghirardello • Andrea Doria Received: 1 August 2014 / Accepted: 22 August 2014 / Published online: 10 September 2014 Ó Springer International Publishing Switzerland 2014 Abstract The gold standard to characterize idiopathic Keywords Inflammatory myopathy Á Autoimmune inflammatory myopathies is the morphological, immuno- myositis Á Histopathology Á Differential diagnosis histochemical and immunopathological analysis of muscle biopsy. Mononuclear cell infiltrates and muscle fiber necrosis are commonly shared histopathological features. Introduction Inflammatory cells that surround, invade and destroy healthy muscle fibers expressing MHC class I antigen are Idiopathic inflammatory myopathies (IIM) are a heteroge- the typical pathological finding of polymyositis. Perifas- neous group of acquired muscle diseases, which have dis- cicular atrophy and microangiopathy strongly support a tinct clinical, pathological and histological features [1, 2]. diagnosis of dermatomyositis. Randomly distributed The most common IIM seen in clinical practice can be necrotic muscle fibers without mononuclear cell infiltrates separated into four categories including polymyositis (PM), represent the histopathological hallmark of immune-med- dermatomyositis (DM), immune-mediated necrotizing iated necrotizing myopathy; meanwhile, endomysial myopathy (NM) and sporadic inclusion body myositis inflammation and muscle fiber degeneration are the two (sIBM) [1, 3]. main pathological features in sporadic inclusion body In the diagnostic workup of an inflammatory myopathy, myositis. A correct differential diagnosis requires immu- muscle biopsy is an indispensable and sensitive tool for nopathological analysis of the muscle biopsy and has establishing the diagnosis.
    [Show full text]
  • NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial
    Journal ofNeurology, Neurosurgery, and Psychiatry 1991;54:285-287 285 J Neurol Neurosurg Psychiatry: first published as 10.1136/jnnp.54.4.285 on 1 April 1991. Downloaded from Joural of NEUROLOGY NEUROSURGERY & PSYCHIATRY Editorial The idiopathic inflammatory myopathies and their treatment The inflammatory myopathies are the largest group of As new knowledge has accumulated over the course of acquired myopathies of adult life and may also occur in the last 10 years, it has become increasingly clear that there infancy and childhood. They have in common the presence are distinct pathological and immunological differences of inflammatory infiltrates within skeletal muscle, usually between polymyositis on the one hand and dermato- in association with muscle fibre destruction. They can be myositis on the other, though in some cases there is clearly subdivided into those which are due to known viral, an overlap between the two conditions. In polymyositis bacterial, protozoal or other microbial agents and those in there is usually scattered necrosis of single muscle fibres which no such agent can be identified and in which which appear hyalinised in the early stages and are immunological mechanisms have been implicated.' The subsequently invaded by mononuclear phagocytic cells. latter group includes polymyositis, dermatomyositis and Regenerating fibres are usually seen singly or in small inclusion body myositis. The evidence for an autoimmune groups distributed focally and randomly throughout the aetiology consists of: 1) an association with other auto- muscle. The inflammatory cell infiltrate is predominantly immune diseases; 2) serological tests which reflect an intrafascicular (endomysial) surrounding muscle fibres altered immune state; and 3) the responsiveness of rather than in the interfascicular septa, though perivascular polymyositis and dermatomyositis, if not of the inclusion infiltrates may also be found; the cellular infiltrate consists body variety, to immunotherapy.2 Polymyositis may rarely mainly of lymphocytes, plasma cells and macrophages.
    [Show full text]
  • Wheaton College Catalog 2003-2005 (Pdf)
    2003/2005 CATALOG WHEATON COLLEGE Norton, Massachusetts www.wheatoncollege.edu/Catalog College Calendar Fall Semester 2003–2004 Fall Semester 2004–2005 New Student Orientation Aug. 30–Sept. 2, 2003 New Student Orientation Aug. 28–Aug. 31, 2004 Labor Day September 1 Classes Begin September 1 Upperclasses Return September 1 Labor Day (no classes) September 6 Classes Begin September 3 October Break October 11–12 October Break October 13–14 Mid-Semester October 20 Mid-Semester October 22 Course Selection Nov. 18–13 Course Selection Nov. 10–15 Thanksgiving Recess Nov. 24–28 Thanksgiving Recess Nov. 26–30 Classes End December 13 Classes End December 12 Review Period Dec. 14–15 Review Period Dec. 13–14 Examination Period Dec. 16–20 Examination Period Dec. 15–20 Residence Halls Close Residence Halls Close (9:00 p.m.) December 20 (9:00 p.m.) December 20 Winter Break and Winter Break and Internship Period Dec. 20 – Jan. 25, 2005 Internship Period Dec. 20–Jan. 26, 2004 Spring Semester Spring Semester Residence Halls Open Residence Halls Open (9:00 a.m.) January 25 (9:00 a.m.) January 27, 2004 Classes Begin January 26 Classes Begin January 28 Mid–Semester March 11 Mid–Semester March 12 Spring Break March 14–18 Spring Break March 15–19 Course Selection April 11–15 Course Selection April 12–26 Classes End May 6 Classes End May 7 Review Period May 7–8 Review Period May 8–9 Examination Period May 9–14 Examination Period May 10–15 Commencement May 21 Commencement May 22 First Semester Deadlines, 2004–2005 First Semester Deadlines, 2003–2004 Course registration
    [Show full text]
  • 2019 Impact Report
    2019 IMPACT REPORT Honouring Excellence. Preserving History. Inspiring Generations. We invite you to be inspired. FROM OUR BOARD CHAIR AND EXECUTIVE DIRECTOR It is an exciting time at the CMHF as we advance our mission thanks to vital and MISSION meaningful partnerships at many levels and the impacts of our programs in our 25th year of service are detailed well on the pages that follow. We are encouraged that our Recognize and celebrate capacity to do more going forward was strengthened this year with significant partner Canadian heroes whose investments: substantial operational support from the Canadian Medical Association work has advanced (CMA) for three years commencing in 2020 and program support from MD Financial health; inspire the Management across all our programs, including the Discovery Days in Health Sciences pursuit of careers in national presenting sponsorship. the health sciences. Change was also a theme for us in 2019 and it came in many forms: • After 16 years, we transitioned to temporary space at 100 Kellogg Lane in London, VISION ON in anticipation of developing our new Exhibit Hall space and offices in the North A Canada that honours Tower in 2020. This exciting, interactive destination will be home to the Children’s our medical heroes – Museum, an indoor adventure park, retail markets, a boutique hotel and an active those of the past, outdoor courtyard to name a few; an amazing co-location model that means more present and future. guests will experience the sense of pride we know comes with exploring our physical Laureate displays. • We undertook a review of our corporate identity and unveiled a new and contemporary brand, look and feel across all our programs.
    [Show full text]
  • Encyclopedia of Women in Medicine.Pdf
    Women in Medicine Women in Medicine An Encyclopedia Laura Lynn Windsor Santa Barbara, California Denver, Colorado Oxford, England Copyright © 2002 by Laura Lynn Windsor All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, except for the inclusion of brief quotations in a review, without prior permission in writing from the publishers. Library of Congress Cataloging-in-Publication Data Windsor, Laura Women in medicine: An encyclopedia / Laura Windsor p. ; cm. Includes bibliographical references and index. ISBN 1–57607-392-0 (hardcover : alk. paper) 1. Women in medicine—Encyclopedias. [DNLM: 1. Physicians, Women—Biography. 2. Physicians, Women—Encyclopedias—English. 3. Health Personnel—Biography. 4. Health Personnel—Encyclopedias—English. 5. Medicine—Biography. 6. Medicine—Encyclopedias—English. 7. Women—Biography. 8. Women—Encyclopedias—English. WZ 13 W766e 2002] I. Title. R692 .W545 2002 610' .82 ' 0922—dc21 2002014339 07 06 05 04 03 02 10 9 8 7 6 5 4 3 2 1 ABC-CLIO, Inc. 130 Cremona Drive, P.O. Box 1911 Santa Barbara, California 93116-1911 This book is printed on acid-free paper I. Manufactured in the United States of America For Mom Contents Foreword, Nancy W. Dickey, M.D., xi Preface and Acknowledgments, xiii Introduction, xvii Women in Medicine Abbott, Maude Elizabeth Seymour, 1 Blanchfield, Florence Aby, 34 Abouchdid, Edma, 3 Bocchi, Dorothea, 35 Acosta Sison, Honoria, 3 Boivin, Marie
    [Show full text]
  • Connective Tissue 5.2.04
    Other Connective Tissue Diseases Chester V. Oddis, MD Thomas A. Medsger, Jr, MD Arthur Weinstein, MD Contents 1. Undifferentiated Connective Tissue Disease 2. Idiopathic Inflammatory Myopathy 3. Scleroderma 4. Sjögren’s Syndrome 5. References OTHER CONNECTIVE TISSUE DISEASES 1 1. Undifferentiated Connective Tissue Disease Table 1 The American College of Rheumatology (ACR) has published criteria for several different diseases Clinical Features and Autoantibody Findings commonly referred to as connective tissue disease Possibly Specific for a Defined CTD (CTD). The primary aim of such classification crite - ria is to ensure the comparability among CTD stud - ies in the scientific community. These diseases Clinical Feature include rheumatoid arthritis (RA), systemic sclero - sis (SSc), systemic lupus erythematosus (SLE), Malar rash polymyositis (PM), dermatomyositis (DM), and Sjögren’s syndrome (SS). These are systemic Subacute cutaneous lupus rheumatic diseases which reflects their inflamma - tory nature and protean clinical manifestations with Sclerodermatous skin changes resultant tissue injury. Although there are unifying immunologic features that pathogenetically tie Heliotrope rash these separate CTDs to each other, the individual disorders often remain clinically and even serologi - Gottron’s papules cally distinct. Immunogenetic data and autoanti - body findings in the different CTDs lend further Erosive arthritis support for their distinctive identity and often serves to subset the individual CTD even further, as seen with the myositis syndromes, SLE and SSc. In other cases, it remains difficult to classify individuals Autoantibody with a combination of signs, symptoms, and labora - tory test results. It is this group of patients that have Anti-dsDNA an “undifferentiated” connective tissue disease (UCTD), or perhaps more accurately, an undifferen - Anti-Sm tiated systemic rheumatic disease.
    [Show full text]
  • Pathological Evaluation of Probiotic, Bacillus Subtilis, Against
    Journal of American Science, 2011; 7(2) http://www.americanscience.org Pathological Evaluation of Probiotic, Bacillus Subtilis, against Flavobacterium columnare in Tilapia Nilotica (Oreochromis Niloticus) Fish in Sharkia Governorate, Egypt Mohamed H Mohamed and Nahla AG Ahmed Refat Dept of Vet. Pathology, Fac Vet Medicine, Zagazig University, 44519 Zagazig City, Egypt. Nahla_kashmery@hotmail [email protected] Abstract: Fifteen out-of eighty-five of collected Tilapia nilotica fish (17.64%) showing skin lesions, were positive for Flavobacterium columnare with cultural, morphological and biochemical characteristics. These skin lesions were large erosions with loss of scales and red-grayish patches, particularly at the frontal head region and abdomen. All of the positive isolates (Flavobacterium columnare) were molecularly tested by means of PCR. With consistent with F. columnare standard ATCC 49512 strain, these isolates produced a 675 bp band. One hundred apparently healthy Tilapia nilotica fingerlings (30±5 gm) were used to evaluate the effectiveness of probiotic, Bacillus subtilis, in water or diet against the intramuscular challenge with Flavobacterium columnare infection. They were equally divided into 10 groups (10 fish for each group). Five groups were experimental control {placebo (gp 1), intramuscularly infected with 0.2 x108 F. columnare CFU (gp 2), received 0.1 gm/L probiotic in water (gp 3), 0.2 gm /L probiotic in fish diet (gp 4), or 1 gm/L oxytetracycline (gp 5)}; two were prophylactic experiment {received 0.1 (gp 6) or 0.2 (gp 7) gm of probiotic in water and diet, respectively 2 months before bacterial infection and continued for a week later}; and three were treated experiment {intramuscularly infected with 0.2 x108 F.
    [Show full text]
  • By the Numbers Excellence, Innovation, Leadership: Research at the University of Toronto a Powerful Partnership
    BY THE NUMBERS EXCELLENCE, INNOVATION, LEADERSHIP: RESEARCH AT THE UNIVERSITY OF TORONTO A POWERFUL PARTNERSHIP The combination of U of T and the 10 partner hospitals affiliated with the university creates one of the world’s largest and most innovative health research forces. More than 1,900 researchers and over 4,000 graduate students and postdoctoral fellows pursue the next vital steps in every area of health research imaginable. UNIVERSITY OF TORONTO Sunnybrook Health St. Michaelʼs Sciences Centre Hospital Womenʼs College Bloorview Kids Hospital Rehab A POWERFUL PARTNERSHIP Baycrest Mount Sinai Hospital The Hospital University Health for Sick Children Network* Centre for Toronto Addiction and Rehabilitation Mental Health Institute *Composed of Toronto General, Toronto Western and Princess Margaret Hospitals 1 UNIVERSITY OF TORONTO FACULTY EXCELLENCE U of T researchers consistently win more prestigious awards than any other Canadian university. See the end of this booklet for a detailed list of awards and honours received by our faculty in the last three years. Faculty Honours (1980-2009) University of Toronto compared to awards held at other Canadian universities International American Academy of Arts & Sciences* Gairdner International Award Guggenheim Fellows National Academies** Royal Society Fellows Sloan Research Fellows American Association for the Advancement of Science* ISI Highly-Cited Researchers*** 0 20 40 60 801 00 Percentage National Steacie Prize Molson Prize Federal Granting Councilsʼ Highest Awards**** Killam Prize Steacie
    [Show full text]